S. Cerevisiae Emergence of an Opportunistic Pathogen
机会性病原体的酿酒酵母的出现
基本信息
- 批准号:7185090
- 负责人:
- 金额:$ 31.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-03-01 至 2009-02-28
- 项目状态:已结题
- 来源:
- 关键词:Antifungal TherapyClinicalComplementComplexDevelopmentFungal Drug ResistanceFutureGenesGeneticGenetic VariationGenomeGenotypeGoalsGrowthHealthHereditary DiseaseHigh temperature of physical objectHumanHuman bodyIn VitroInfectionLaboratoriesLaboratory miceMapsModelingMusNaturePathogenesisPathogenicityPathway interactionsPhenotypePopulationProcessProliferatingQuantitative GeneticsQuantitative Trait LociRelative (related person)Research PersonnelSNP genotypingSaccharomyces cerevisiaeSiteTestingVirulenceVirulentbasefungusgenome sequencingimprovedin vivoinsightkillingsmicrobialmicroorganismpathogensugartrait
项目摘要
The broad long term goals of this project are: 1.) To develop a detailed understanding of the emergence of S. cerevisiae as an opportunistic pathogen. 2.) To develop S. cerevisiae as a robust model to study the genetically complex phenotypes of pathogenicity and virulence. & 3.) To develop S. cerevisiae as a robust microbial model to study quantitative genetics.
The specific aims of this project are: 1.) To determine the genetic basis for the very low in vivo survival-proliferation of the laboratory (S288c) strain and the very high in vivo survival-proliferation of the clinically derived (YJM145) strain S. cerevisiae genetic backgrounds. 2.) To determine the genetic basis for the difference between the non-lethal $288c and lethal YJM145 infection phenotypes. 3.) To examine a large S. cerevisiae population and determine the generality of virulence phenotypes and genotypes.
The health relatedness of this project is twofold. First, the identification of the genes that differ between (i) low vs. high in vivo survival-proliferation and (ii) non-lethal vs. lethal strains ofS. cerevisiae is informative with respect to both the emergence of an opportunistic pathogen and what pathogen fungi require to survive-proliferate in and kill the host. Second, examination of the S. cerevisiae population will tell us the generality of virulence and virulence related phenotypes and genotypes. In both cases, we gain insight into the basics of fungal virulence that will aid in the development of antifungal therapies. Unfortunately the underlying basis of fungal pathogenesis is very poorly understood. Using S. cerevisiae, both in vivo survival-proliferation and lethal infections can be examined in ways that are not feasible in more common pathogenic fungi. Understanding the underlying basis of in vivo survival-proliferation and lethal infections aids our understanding of these processes in other pathogenic fungi. We will achieve these goals (i) by mapping the loci/identifying the genes responsible for the in vivo survival-proliferation phenotype and (ii) examining the larger S. cerevisiae population both phenotypically, for virulence and virulence-associated traits, and genotypically, for virulence-related genes.
该项目的长期目标是:(1)对S.酿酒酵母作为机会致病菌。2.)的情况。发展S.酿酒酵母作为一个强大的模型,研究遗传复杂的表型的致病性和毒力。和3.)发展S.酿酒酵母作为一个强大的微生物模型,研究数量遗传学。
该项目的具体目标是:(1)。为确定实验室菌株(S288 c)极低的体内存活-增殖和临床衍生菌株(YJM 145)极高的体内存活-增殖的遗传基础。酿酒酵母的遗传背景。2.)的情况。确定非致死性$288c和致死性YJM 145感染表型之间差异的遗传基础。3.)第三章检查一个大的S。酿酒酵母群体,并确定毒力表型和基因型的一般性。
该项目的健康相关性是双重的。首先,鉴定在(i)低与高体内存活-增殖和(ii)非致死与致死S.酿酒酵母菌提供关于机会致病菌的出现和致病真菌需要什么来在宿主中存活-增殖和杀死宿主的信息。第二,对S.酿酒酵母群体的毒性和毒性相关的表型和基因型的一般性。在这两种情况下,我们深入了解真菌毒力的基础知识,这将有助于抗真菌治疗的发展。不幸的是,对真菌发病机理的基础了解甚少。利用S.酿酒酵母,无论是在体内存活增殖和致死感染可以检查的方式,是不可行的,在更常见的病原真菌。了解体内存活增殖和致死性感染的潜在基础有助于我们了解其他病原真菌中的这些过程。我们将实现这些目标(i)通过定位基因座/鉴定负责体内存活-增殖表型的基因和(ii)检查较大的S。酿酒酵母群体的毒力和毒性相关性状在表型上,以及毒性相关基因在基因型上。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John H. McCusker其他文献
John H. McCusker的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John H. McCusker', 18)}}的其他基金
S. Cerevisiae Emergence of an Opportunistic Pathogen
机会性病原体的酿酒酵母的出现
- 批准号:
7900266 - 财政年份:2009
- 资助金额:
$ 31.02万 - 项目类别:
ANALYSIS OF GENETICALLY & ENVIRONMENTALLY OVERLAPPING YEAST QUANTITATIVE TRAITS
遗传分析
- 批准号:
7300716 - 财政年份:2007
- 资助金额:
$ 31.02万 - 项目类别:
ANALYSIS OF GENETICALLY & ENVIRONMENTALLY OVERLAPPING YEAST QUANTITATIVE TRAITS
遗传分析
- 批准号:
7894666 - 财政年份:2007
- 资助金额:
$ 31.02万 - 项目类别:
Fungal-specific drug targets: static vs. cidal starvation & toxic intermediates
真菌特异性药物靶点:静态饥饿与杀菌饥饿
- 批准号:
7470634 - 财政年份:2007
- 资助金额:
$ 31.02万 - 项目类别:
Fungal-specific drug targets: static vs. cidal starvation & toxic intermediates
真菌特异性药物靶点:静态饥饿与杀菌饥饿
- 批准号:
7253839 - 财政年份:2007
- 资助金额:
$ 31.02万 - 项目类别:
ANALYSIS OF GENETICALLY & ENVIRONMENTALLY OVERLAPPING YEAST QUANTITATIVE TRAITS
遗传分析
- 批准号:
7476572 - 财政年份:2007
- 资助金额:
$ 31.02万 - 项目类别:
ANALYSIS OF GENETICALLY & ENVIRONMENTALLY OVERLAPPING YEAST QUANTITATIVE TRAITS
遗传分析
- 批准号:
7664948 - 财政年份:2007
- 资助金额:
$ 31.02万 - 项目类别:
S. Cerevisiae Emergence of an Opportunistic Pathogen
机会性病原体的酿酒酵母的出现
- 批准号:
7369742 - 财政年份:2005
- 资助金额:
$ 31.02万 - 项目类别:
S. Cerevisiae Emergence of an Opportunistic Pathogen
机会性病原体的酿酒酵母的出现
- 批准号:
7025020 - 财政年份:2005
- 资助金额:
$ 31.02万 - 项目类别:
S. Cerevisiae Emergence of an Opportunistic Pathogen
机会性病原体的酿酒酵母的出现
- 批准号:
6870918 - 财政年份:2005
- 资助金额:
$ 31.02万 - 项目类别:
相似国自然基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Reducing time, sample handling, and staff requirements for complement activation monitoring in clinical trials
减少临床试验中补体激活监测的时间、样品处理和人员需求
- 批准号:
9141919 - 财政年份:2016
- 资助金额:
$ 31.02万 - 项目类别:
Exhaustive analysis for clinical application of anti-complement drugs
抗补体药物临床应用详尽分析
- 批准号:
15K09502 - 财政年份:2015
- 资助金额:
$ 31.02万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Complement activation as a therapeutic target and clinical biomarker for Parkinson's disease
补体激活作为帕金森病的治疗靶点和临床生物标志物
- 批准号:
nhmrc : 1082250 - 财政年份:2015
- 资助金额:
$ 31.02万 - 项目类别:
Project Grants
The effect of genetic polymorphism in complement proteins on clinical renal transplant outcome
补体蛋白基因多态性对临床肾移植结局的影响
- 批准号:
G0701320/1 - 财政年份:2008
- 资助金额:
$ 31.02万 - 项目类别:
Research Grant
Complement Genetics and Clinical Variability of Systemic Lupus Erythematosus
系统性红斑狼疮的补体遗传学和临床变异
- 批准号:
8327290 - 财政年份:2008
- 资助金额:
$ 31.02万 - 项目类别:
Complement Genetics and Clinical Variability of Systemic Lupus Erythematosus
系统性红斑狼疮的补体遗传学和临床变异
- 批准号:
7906020 - 财政年份:2008
- 资助金额:
$ 31.02万 - 项目类别:
Complement Genetics and Clinical Variability of Systemic Lupus Erythematosus
系统性红斑狼疮的补体遗传学和临床变异
- 批准号:
7467641 - 财政年份:2008
- 资助金额:
$ 31.02万 - 项目类别:
Complement Genetics and Clinical Variability of Systemic Lupus Erythematosus
系统性红斑狼疮的补体遗传学和临床变异
- 批准号:
7680116 - 财政年份:2008
- 资助金额:
$ 31.02万 - 项目类别:
Complement Genetics and Clinical Variability of Systemic Lupus Erythematosus
系统性红斑狼疮的补体遗传学和临床变异
- 批准号:
8123298 - 财政年份:2008
- 资助金额:
$ 31.02万 - 项目类别:
Clinical application of evaluation of complement protein levels in the exocrine pancreas to determine the pancreatic disease activity
评估胰腺外分泌补体蛋白水平以确定胰腺疾病活动度的临床应用
- 批准号:
09470135 - 财政年份:1997
- 资助金额:
$ 31.02万 - 项目类别:
Grant-in-Aid for Scientific Research (B)














{{item.name}}会员




